The ketogenic diet is a high- fat , adequate- protein , low-carbohydrate diet that in medicine is used mainly to treat hard-to-control refractory epilepsy in children. The diet forces the body to burn fats rather than carbohydrates. Normally carbohydrates in food are converted into glucose , which is then transported around the body and is important in fueling brain function. But if little carbohydrate remains in the diet, the liver converts fat into fatty acids and ketone bodies , the latter passing into the brain and replacing glucose as an energy source. An elevated level of ketone bodies in the blood a state called ketosis eventually lowers the frequency of epileptic seizures.

Author:Zulkijas Mikaran
Language:English (Spanish)
Published (Last):18 August 2013
PDF File Size:2.68 Mb
ePub File Size:15.9 Mb
Price:Free* [*Free Regsitration Required]

Alzheimer's disease is a neurodegenerative disorder characterized by a progressive memory loss table. Self-care skills and cognitive functions are seen insufficiency. Although pathologically identified with amyloid plaques, excessive phosphorylation of the tau protein and consequent neurofibrillary tangle formation, and neuronal loss may be associated with Alzheimer's disease.

Negative effects of amyloid plaques and tau proteins can result in many causes such as oxidative stress, impaired glucose homeostasis. Treatment methods developed against pathogens can also be varied. A diet rich in antioxidants against oxidative stress, ketogenic diet versus the deterioration of glucose metabolism in Alzheimer's is located in the dietary treatment of disease.

In addition, eicosapentaenoic acid EPA and decozahexenoic acid DHA of long chain n-3 fatty acids have been implicated in the development of cognitive functions due to antiinflammatory effects. In this review, it has been examined that the effects of fatty acids on metabolic processes in Alzheimer's disease, delayed progression and treatment of disease. Zotero Mendeley EndNote. Alzheimers Dement ; 3 3 : — Toda N, Okamura T. J Pharmacol Sci ; 4 : — Herbert J, Lucassen PJ.

Front Neuroendocr ; — Neurol Clin ; 34 4 : — Oxidative stress, protein modification and Alzheimer disease. Brain Res Bull ; Biomed Pharmacother ; 39— Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol ; 64 1 : 86— Homocysteine and folate as risk factors for dementia and Alzheimer disease.

Am J Clin Nutr ; 82 3 : — Agrawal R, Gomez-Pinilla F. J Physiol ; Pt 10 : — Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pr Neurol ; 5 3 : — Kumar A, Singh A, Ekavali. Pharmacol Rep ; 67 2 : — Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol ; 82 4 : — Esen S. Turkish Journal Of Geriatrics ; 13 3 : Division, ; p.

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

Arch Neurol ; 61 3 : — Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest ; 5 : —9. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Neurobiol Aging [Internet] [cited Jan 19]; 21 3 : — Neurochem Int [Internet] [cited Jan 19]; 39 5—6 : — Davis KL.

Interview by Alice V. Geriatrics [Internet] Feb [cited Jan 19]; 54 2 : 42—7. Glucosinolates and isothiocyanates in health and disease. Trends Mol Med [Internet] [cited Mar 23]; 18 6 : — Fatty acids and their therapeutic potential in neurological disorders. Neurochem Int [Internet] May [cited Mar 23]; 75— Fatty Acids and the Aging Brain. Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol [Internet] [cited Mar 23]; 1 : — Dietary fatty acids intake: possible role in cognitive decline and dementia.

Exp Gerontol [Internet] [cited Mar 23]; 40 4 : — Simopoulos AP. Mol Neurobiol ; 44 2 : — Biomed Pharmacother ; 56 8 : — Br J Nutr ; 1 : 1— Clin Exp Pharmacol Physiol ; 33 10 : —9. PLoS One ; 10 3 : e Exp Neurol ; 1 : 88— A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells.

Biochim Biophys Acta - Biomembr ; 10 : — Biochem Soc Symp ; — J Int Neuropsychol Soc ; 20 10 : — Wang D, Zheng W. Dietary cholesterol concentration affects synaptic plasticity and dendrite spine morphology of rabbit hippocampal neurons. Brain Res ; — Dement Geriatr Cogn Disord ; 28 1 : 75— Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study.

J Neurol Sci ; 1—2 : 79— Hughes T, Ganguli M. Curr Psychiatry Rev [Internet]. Neurobiol Aging ; 34 9 : — Neurobiol Aging ; — Trends Mol Med ; 16 10 : — Grant WB. Lane-Donovan C, Herz J. PLoS One [Internet]. Nutrients ; 6 9 : — Schmitz G, Ecker J. J Agric Food Chem ; 51 24 : — J Am Geriatr Soc ; 59 5 : — Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int ; Neurobiol Aging ; 34 6 : —9. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.

J Lipid Res ; 55 9 : — DOI: Tam Metin.


Ketokolik - Ketojenik Diyet

In the world of weight-loss diets, low-carbohydrate, high-protein eating plans often grab attention. The Paleo, South Beach, and Atkins diets all fit into that category. They are sometimes referred to as ketogenic or "keto" diets. But a true ketogenic diet is different. And it's not the type of diet to try as an experiment. While it also has been tried for weight loss , only short-term results have been studied, and the results have been mixed. We don't know if it works in the long term, nor whether it's safe," warns registered dietitian Kathy McManus, director of the Department of Nutrition at Harvard-affiliated Brigham and Women's Hospital.


Ketojenik diyet nedir? Ketojenik beslenme diyeti nasıl yapılır? Yan etkileri nelerdir?


Related Articles